ARCHIVES

Wallen Pleads Guilty To Lesser Charges, To Pay $20,000 to CALGB, FDA

This article is from The Cancer Letter archive.

Vol. 10 No. 33 | August 31, 1984

Download PDF Visit The Full Archive

Related Articles

Only 20% of Doctors Advise CRC According To Guidelines

October 29, 2010

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

October 25, 2013

DCCR Plans Three Multiple Contracts In Pain Control

February 17, 1978

AACR President: Cancer Program ‘Threatened,’ Calls For Strategic Plan, More Extramural Input

December 6, 1991

NCI Programs: Pediatric Brain Tumor Grants Awarded

April 16, 1999

NCI Biostatistician Calls For Reanalysis Of Canadian Breast Screening Study

February 10, 1995